Universal Health Services, Inc. (UHS)

FairStock Score: 79/100 — HIGH CONVICTION

Key Financials

Strengths

• Strong profitability with 9.94% net margin and 21.33% ROE demonstrating operational excellence
• Diversified revenue streams across acute care and behavioral health services with essential healthcare positioning
• Consistent free cash flow generation of $565.3M annually supporting debt service and capital allocation
• Large scale with 78,400 employees providing operational leverage and market presence
• Favorable demographic trends supporting long-term healthcare utilization growth

Concerns

• Valuation premium of 34.35% above Graham Number suggests limited margin of safety at current price
• Elevated EV/EBITDA of 21.49x and modest FCF yield of 2.4% offer poor risk-reward profile
• Low ROCE of 8.31% indicates capital allocation challenges relative to capital intensity of business
• Vulnerability to healthcare policy changes, Medicare/Medicaid reimbursement pressure, and wage inflation
• Altman Z-Score of 2.01 suggests elevated financial stress requiring careful monitoring

AI Analysis

Universal Health Services presents a paradox worthy of careful scrutiny. On the surface, we see a healthcare operator with solid fundamentals: $4.5B in quarterly revenue, a 9.94% net margin, and impressive 21.33% ROE. The company generates meaningful free cash flow of $565.3M annually, and operates in an essential sector with demographic tailwinds. However, I must exercise caution here. The current price of $186.53 sits 34.35% above Graham's calculated fair value of $138.84, a significant premium that demands justification. The EV/EBITDA multiple of 21.49x is elevated for a mature healthcare operator, and the modest FCF yield of 2.4% offers limited margin of safety. While the Piotroski F-Score of 7/9 suggests reasonable financial quality, the Altman Z-Score of 2.01 indicates some financial stress—not critical, but worth monitoring. The debt-to-equity ratio of 0.70 is manageable but not negligible. What troubles me most is the valuation disconnect. Healthcare facilities are capital-intensive, cyclical businesses vulnerable to regulatory changes, reimbursement pressure, and labor inflation. The company's ROCE of 8.31% is disappointing for a firm requiring such capital deployment. I'm observing a business of adequate quality trading at a speculative price. For value investors, this warrants patience rather than conviction.

Bull Case

Healthcare utilization accelerates post-pandemic as delayed procedures resume, driving operating leverage on fixed cost base. Behavioral health segment experiences sustained demand growth as mental health awareness increases, commanding premium reimbursement rates and margins.

Bear Case

Rising labor costs and wage inflation erode margins while regulatory pressures and value-based care reimbursement models compress pricing power. Economic recession reduces elective procedures and increases charity care obligations, pressuring near-term earnings and cash flow.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer